Alexander Nichols

President and Chief Operating OfficeratenGene Therapeutics· In the 2023 proxy

Pay in FY2023

Alexander Nichols was paid $970.0K in FY2023 (Oct).

PayNo stock prices for these years

Pay is from the Summary Compensation Table of each enGene Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

ENGN
enGene TherapeuticsPublic company · 3 yr
- President and Chief Operating Officer2023 – Present · 3 yrStock in role -92%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?